134 related articles for article (PubMed ID: 2790114)
1. Changing frequency of interim analysis in sequential monitoring.
Lan KK; DeMets DL
Biometrics; 1989 Sep; 45(3):1017-20. PubMed ID: 2790114
[TBL] [Abstract][Full Text] [Related]
2. Futility interim monitoring with control of type I and II error probabilities using the interim Z-value or confidence limit.
Lachin JM
Clin Trials; 2009 Dec; 6(6):565-73. PubMed ID: 19933716
[TBL] [Abstract][Full Text] [Related]
3. Over-ruling a group sequential boundary--a stopping rule versus a guideline.
Lan KK; Lachin JM; Bautista O
Stat Med; 2003 Nov; 22(21):3347-55. PubMed ID: 14566919
[TBL] [Abstract][Full Text] [Related]
4. Design and analysis of group sequential logrank tests in maximum duration versus information trials.
Kim K; Boucher H; Tsiatis AA
Biometrics; 1995 Sep; 51(3):988-1000. PubMed ID: 7548714
[TBL] [Abstract][Full Text] [Related]
5. A review of methods for futility stopping based on conditional power.
Lachin JM
Stat Med; 2005 Sep; 24(18):2747-64. PubMed ID: 16134130
[TBL] [Abstract][Full Text] [Related]
6. Stopping clinical trials early for benefit: impact on estimation.
Freidlin B; Korn EL
Clin Trials; 2009 Apr; 6(2):119-25. PubMed ID: 19342463
[TBL] [Abstract][Full Text] [Related]
7. Implementation of group sequential logrank tests in a maximum duration trial.
Lan KK; Lachin JM
Biometrics; 1990 Sep; 46(3):759-70. PubMed ID: 2242413
[TBL] [Abstract][Full Text] [Related]
8. An adaptive approach to implementing bivariate group sequential clinical trial designs.
Todd S
J Biopharm Stat; 2003 Nov; 13(4):605-19. PubMed ID: 14584711
[TBL] [Abstract][Full Text] [Related]
9. A decision rule for sequential monitoring of clinical trials with a primary and supportive outcome.
Zhao Y; Grambsch PM; Neaton JD
Clin Trials; 2007; 4(2):140-53. PubMed ID: 17456513
[TBL] [Abstract][Full Text] [Related]
10. Exact permutational tests for group sequential clinical trials.
Mehta CR; Patel N; Senchaudhuri P; Tsiatis A
Biometrics; 1994 Dec; 50(4):1042-53. PubMed ID: 7786986
[TBL] [Abstract][Full Text] [Related]
11. Optimal conditional error functions for the control of conditional power.
Brannath W; Bauer P
Biometrics; 2004 Sep; 60(3):715-23. PubMed ID: 15339294
[TBL] [Abstract][Full Text] [Related]
12. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
Lewis RJ; Lipsky AM; Berry DA
Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
[TBL] [Abstract][Full Text] [Related]
13. Clinical trial designs based on sequential conditional probability ratio tests and reverse stochastic curtailing.
Tan M; Xiong X; Kutner MH
Biometrics; 1998 Jun; 54(2):682-95. PubMed ID: 9629648
[TBL] [Abstract][Full Text] [Related]
14. Operating characteristics of sample size re-estimation with futility stopping based on conditional power.
Lachin JM
Stat Med; 2006 Oct; 25(19):3348-65. PubMed ID: 16345019
[TBL] [Abstract][Full Text] [Related]
15. Standard versus adaptive monitoring procedures: A commentary.
Fleming TR
Stat Med; 2006 Oct; 25(19):3305-12; discussion 3313-4, 3326-47. PubMed ID: 16850447
[TBL] [Abstract][Full Text] [Related]
16. Increasing the sample size when the unblinded interim result is promising.
Chen YH; DeMets DL; Lan KK
Stat Med; 2004 Apr; 23(7):1023-38. PubMed ID: 15057876
[TBL] [Abstract][Full Text] [Related]
17. Interim analyses for randomized clinical trials: the group sequential approach.
Pocock SJ
Biometrics; 1982 Mar; 38(1):153-62. PubMed ID: 7082757
[TBL] [Abstract][Full Text] [Related]
18. Assessment of futility in clinical trials.
Snapinn S; Chen MG; Jiang Q; Koutsoukos T
Pharm Stat; 2006; 5(4):273-81. PubMed ID: 17128426
[TBL] [Abstract][Full Text] [Related]
19. Confidence intervals following group sequential tests in clinical trials.
Kim K; DeMets DL
Biometrics; 1987 Dec; 43(4):857-64. PubMed ID: 3427170
[TBL] [Abstract][Full Text] [Related]
20. Optimal continuous sequential boundaries for monitoring toxicity in clinical trials: a restricted search algorithm.
Goldman AI; Hannan PJ
Stat Med; 2001 Jun; 20(11):1575-89. PubMed ID: 11391689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]